BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21267505)

  • 1. The first C-glycosidic analogue of a novel galactosyltransferase inhibitor.
    Descroix K; Wagner GK
    Org Biomol Chem; 2011 Mar; 9(6):1855-63. PubMed ID: 21267505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel fluorescent probe for retaining galactosyltransferases.
    Pesnot T; Palcic MM; Wagner GK
    Chembiochem; 2010 Jul; 11(10):1392-8. PubMed ID: 20533489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of galactosyltransferases by a novel class of donor analogues.
    Descroix K; Pesnot T; Yoshimura Y; Gehrke SS; Wakarchuk W; Palcic MM; Wagner GK
    J Med Chem; 2012 Mar; 55(5):2015-24. PubMed ID: 22356319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of fluorescently labelled and internally quenched UDP-Gal probes.
    Schweizer F
    Carbohydr Res; 2007 Sep; 342(12-13):1831-40. PubMed ID: 17475229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and photolytic activation of 6''-O-2-nitrobenzyl uridine-5'-diphosphogalactose: a 'caged' UDP-Gal derivative.
    Mannerstedt K; Hindsgaul O
    Carbohydr Res; 2008 Apr; 343(5):875-81. PubMed ID: 18275942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise syntheses of selective inhibitors against α-1,3-galactosyltransferase.
    Zhang GL; Zhang LH; Ye XS
    Org Biomol Chem; 2010 Nov; 8(22):5062-8. PubMed ID: 20820649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastereoselective synthesis of novel iminosugar-containing UDP-Galf mimics: potential inhibitors of UDP-Gal mutase and UDP-Galf transferases.
    Liautard V; Christina AE; Desvergnes V; Martin OR
    J Org Chem; 2006 Sep; 71(19):7337-45. PubMed ID: 16958528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of bovine alpha-1,3-galactosyltransferase and its complexes with UDP and DPGal inferred from molecular modeling.
    Rao M; Tvaroska I
    Proteins; 2001 Sep; 44(4):428-34. PubMed ID: 11484220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of beta-1,4- and alpha-1,3-galactosyltransferases: donor sugar-nucleotide based approach.
    Takayama S; Chung SJ; Igarashi Y; Ichikawa Y; Sepp A; Lechler RI; Wu J; Hayashi T; Siuzdak G; Wong CH
    Bioorg Med Chem; 1999 Feb; 7(2):401-9. PubMed ID: 10218835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the retaining galactosyltransferase LgtC from Neisseria meningitidis in complex with donor and acceptor sugar analogs.
    Persson K; Ly HD; Dieckelmann M; Wakarchuk WW; Withers SG; Strynadka NC
    Nat Struct Biol; 2001 Feb; 8(2):166-75. PubMed ID: 11175908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-pot three-enzyme synthesis of UDP-Glc, UDP-Gal, and their derivatives.
    Zou Y; Xue M; Wang W; Cai L; Chen L; Liu J; Wang PG; Shen J; Chen M
    Carbohydr Res; 2013 May; 373():76-81. PubMed ID: 23584237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of uridine 5'-[2-S-pyridyl-3-thio-alpha-D-galactopyranosyl diphosphate]: precursor of UDP-thiogal sugar nucleotide donor substrate for beta-1,4-galactosyltransferase.
    Elhalabi J; Rice KG
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):195-205. PubMed ID: 15043147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of beta1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site.
    Ramakrishnan B; Balaji PV; Qasba PK
    J Mol Biol; 2002 Apr; 318(2):491-502. PubMed ID: 12051854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening a limited structure-based library identifies UDP-GalNAc-specific mutants of alpha-1,3-galactosyltransferase.
    Tumbale P; Jamaluddin H; Thiyagarajan N; Acharya KR; Brew K
    Glycobiology; 2008 Dec; 18(12):1036-43. PubMed ID: 18782853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UDP-6-deoxy-6-fluoro-alpha-D-galactose binds to two different galactosyltransferases, but neither can effectively catalyze transfer of the modified galactose to the appropriate acceptor.
    Schengrund CL; Kovác P
    Carbohydr Res; 1999 Jun; 319(1-4):24-8. PubMed ID: 10520253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific inhibition of an alpha-galactosyltransferase from Trypanosoma brucei by synthetic substrate analogues.
    Kolb V; Amann F; Schmidt RR; Duszenko M
    Glycoconj J; 1999 Sep; 16(9):537-44. PubMed ID: 10815990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of UDP-sugar binding to UDP-galactose 4-epimerase from Escherichia coli.
    Thoden JB; Hegeman AD; Wesenberg G; Chapeau MC; Frey PA; Holden HM
    Biochemistry; 1997 May; 36(21):6294-304. PubMed ID: 9174344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of alpha-galactosyl epitopes via combined use of two recombinant whole cells harboring UDP-galactose 4-epimerase and alpha-1,3-galactosyltransferase.
    Chen X; Zhang W; Wang J; Fang J; Wang PG
    Biotechnol Prog; 2000; 16(4):595-9. PubMed ID: 10933834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. En route to deoxygenated N-acetyllactosamine analogues employing uridyl and galactosyl transferases.
    Lazarevic D; Streicher H; Thiem J
    Carbohydr Res; 2009 Aug; 344(12):1449-52. PubMed ID: 19560126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of UDP-galactose binding by alpha-1,3-galactosyltransferase (alpha3GT): role of negative charge on aspartic acid 316 in structure and activity.
    Tumbale P; Jamaluddin H; Thiyagarajan N; Brew K; Acharya KR
    Biochemistry; 2008 Aug; 47(33):8711-8. PubMed ID: 18651752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.